Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
John Maraganore
Biotech
Biogen blueprints $1B CNS deal with RNAi biotech
City could net up to $1 billion in potential milestone payments tied to an initial CNS program, plus royalties.
Gabrielle Masson
May 27, 2025 10:55am
Biotech CEOs say they already feel impact of FDA restructure
Apr 10, 2025 1:56pm
City Tx breaks ground with $135M, blueprints from Maraganore
Oct 8, 2024 10:38am
Judo throws down $100M to knock out kidney disease
Oct 7, 2024 10:42am
New cell therapy biotech emerges from the lab of George Church
Sep 19, 2024 6:30am
Bayer undergoes leadership shake-up—Chutes & Ladders
Mar 22, 2024 9:30am
